Oblique Therapeutics AB ("Oblique" or the "Company") today announces the outcome of the rights issue that closed on [date].

Akobo Minerals AB (publ) (Euronext Growth Oslo and Frankfurt: AKOBO), the Scandinavian-based Ethiopian gold producer and explorer, today announced its results for the first quarter of 2026. The first ...

Hamlet BioPharma, a pharmaceutical company specializing in the development of novel treatments for cancer and infectious diseases, today announces ...

Many people receiving dialysis treatment believe travel is no longer possible. At the National Kidney Foundation (NKF) Kidney ...

Gobain, a global leader in light and sustainable construction, on the signing of a binding agreement for the sale, at ...

The Stockholm deployment will provide AI innovators with access to CoreWeave's AI cloud platform, designed specifically for ...

Uppsala, Sweden, June 25, 2026 - OssDsign AB (publ.), a leader in next-generation orthobiologic solutions that support the body's natural healing capabilities, today announced Adam McCollister has ...

Hamlet BioPharma today announces the successful release of the Phase III quality batch of Alpha1H for use in clinical trials of bladder cancer in Europe ...

Hamlet BioPharma AB (publ) today announced the signing of a clinical trial agreement with the University of Iowa, one of the leading U.S. centers for bladder cancer research and therapy. The new study ...

The new 10 million Euro contract marks a major milestone in Talkpool's Vision 2030 growth plan as it allows for continuing ongoing work and expanding to ...

STOCKHOLM, SWEDEN - June 17, 2026. Gesynta Pharma AB, a Swedish clinical stage pharmaceutical company focusing on chronic ...

Halvåret är slut och snart väntas rapporterna – efter ett kvartal där Stockholmsbörsen stigit med 10 procent trots ...